Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities

International Journal of Drug Policy

Volumn 25, Issue 2, 2014, Pages 303-307

  Hope, V D ^a,b   Hickman, M ^c   Parry, J V ^a,b   Ncube, F ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

England; Injection site infections and injuries; People who inject drugs

Indexed keywords

AMPHETAMINE; COCAINE; DIAMORPHINE;

ADULT; ADVERSE OUTCOME; ARTICLE; DISEASE ASSOCIATION; DRIED BLOOD SPOT TESTING; FEMALE; HUMAN; INJECTION SITE ABSCESS; INJECTION SITE INFECTION; INJECTION SITE OPEN WOUND; INJECTION SITE REACTION; INJECTION SITE REDNESS; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; COMPLICATION; DRUG ABUSE; INFECTION; NEEDLESTICK INJURIES; SUBSTANCE ABUSE; UNITED KINGDOM; YOUNG ADULT;

ADULT; ENGLAND; FEMALE; HUMANS; INFECTION; MALE; NEEDLE SHARING; NEEDLESTICK INJURIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84896076756     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2013.11.012     Document Type: Article

References (15)

1. Del Giudice P. Cutaneous complications of intravenous drug abuse. British Journal of Dermatology 2004, 150:1-10.
2. Dwyer R., Topp L., Maher L., Power R., Hellard M., Walsh N., et al. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug and Alcohol Dependence 2009, 100:9-16.
3. Gordon R., Lowy F. Bacterial infections in drug users. The New England Journal of Medicine 2005, 353:1945-1954.
4. Harris M., Rhodes T. Venous access and care: Harnessing pragmatics in harm reduction for people who inject drugs. Addiction 2012, 107(6):1090-1096.
5. Heckathorn D. Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems 1997, 44:174-199.
6. Hope V. Neglected infections, real harms: A global scoping of injection-related bacterial infections and responses. The global state of harm reduction: Key issues for broadening the response 2010, 89-96. International Harm Reduction Association, London. C. Cook (Ed.).
7. Hope V., Hickman M., Ngui S., Jones S., Telfer M., Bizzarri M., et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. Journal of Viral Hepatitis 2011, 18:262-270.
8. Hope V., Kimber J., Hickman M., Vickerman P., Ncube F. Factors and cost associated with symptoms with injection site infections in England: Findings from a multi-site survey. BMC Infectious Diseases 2008, 8:120.
9. Kerr T., Wood E., Grafstein E., Ishida T., Shannon K., Lai C., et al. High rates of primary care and emergency department use among injection drug users in Vancouver. Journal of Public Health (Oxford) 2005, 27:62-66.
10. Lloyd-Smith E., Kerr T., Hogg R., Li K., Montaner J., Wood E. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduction Journal 2005, 2:24.
11. Marks M., Pollock E., Armstrong M., Morris-Jones S., Kidd M., Gothard P., et al. Needles and the damage done: Reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital. Journal of Infection 2013, 66:95-102.
12. Morrison A., Elliott L., Gruer L. Injecting-related harm and treatment seeking behaviour among injecting drug users. Addiction 1997, 92:1349-1352.
13. Palepu A., Tyndall M., Leon H., Muller J., O'Shaughnessy M., Schechter M., et al. Hospital utilization and costs in a cohort of injection drug users. Canadian Medical Association Journal 2001, 165:415-420.
14. Pollini R., Gallardo M., Hasan S., Minuto J., Lozada R., Vera A., et al. High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico. International Journal of Infectious Diseases 2010, 14(Suppl. 3):e117-e122.
15. Salmon A., Dwyer R., Jauncey M., van Beek I., Topp L., Maher L. Injecting-related injury and disease among clients of a supervised injecting facility. Drug and Alcohol Dependence 2009, 101:132-136.